Eden Research Share Discussion Threads

[supersonico] 17/6/2016 11:42

Good word count their SK.

Still keeping out of the Swing.

How did Shore Cap hide the TT deal from Livingbridge ?

[sandcrab2] 17/6/2016 11:25

Hi Karolina

I see, like me, you are an Old Africa Hand

JAMBO KAROLINA!

[sweet karolina] 17/6/2016 10:50

supersonico still ducking the questions on Terpenetech, still not explaining why Eden have done nothing about the allegations of fraud and still not explaining why she went back and edited her posts of 8 Jun 2 days later when it became clear she had made a fool of herself yet again.

I can read material that is in the public domain and I can give my honestly held opinion on it, without fear of lawyers. It is my honestly held opinion, based on what is in the public domain, that Eden committed fraud. If Eden ever do live up to their obligations to publish the Terpenetech valuation report, I will read that and reassess my opinion - anyone would think if Eden did not commit fraud they would be keen to get that valuation into the public domain, but it seems that they are not keen for some reason.

It is my honestly held opinion that, like most broker notes, Shore Cap's notes on Eden present a wildly overly optimistic valuation based on sales, which are in turn wildly overly optimistic. Any communication between Shore Cap and placees is not in the public domain, thus it is not possible to express an opinion on it, so trying to suggest that not expressing an opinion in the precise terms demanded is some how an admission that Eden did not commit fraud is patent nonsense, just like all the other nonsense and lies supersonico has posted. Supersonico posted on 8 Jun questioning why TW had not said Shore cap were complicit in misleading investors. TW had said exactly that and when this was pointed out to her she edited her posts and moved the goal posts to willful blindness. I have no opinion on whether it is right or not to say Shore Cap were complicit, other than to observe that Nomads and Brokers have turned blind eyes to many such situations and that Shore Cap have done nothing out of the ordinary for AIM. There is nothing out of the ordinary for so called institutional investors to buy into frauds, they are playing with other peoples' money.

Keep counting the days since FRC were notified of the fraud. If they had found nothing wrong it is likely they would have said so by now. The longer it takes the more likely it is that FRC have found something they need to do more detailed investigation into - that is how it works, but don't let that inconvenient truth stop you from drawing false conclusions and trying to mislead people with those false conclusions.

All in all supersonico and others' pathetic arguments that others must have done extensive DD and that means nothing is wrong are not convincing those who look objectively at the investment case as the shareprice continues to tank, even after the release of seemingly good news. As ever with Eden it is what is not said that is the real issue. How are sales going, are they on track to meet those overly optimistic broker forecasts? Clearly not or they would have take the opportunity to say so. Still no French approval, so it looks like they have missed the boat for this growing season, just as they missed the boat on getting their product into the Sipcam catalogue in Italy.

[quazie12] 17/6/2016 09:51

SK

It's interesting that the Company managed to notify Companies House yesterday of a change in the registered office yet there is still no sign of the Terpenetech Valuation.

When I looked yesterday, the Registered office change had just been received by CH but was not visible to the public, presumably it went through some validation check. It is now possible to view that change this morning.

It would appear on the face of it that the Valuation Report has not actually been lodged yet. It is effectively breaking the law and has been since August 2015.


Companies Act 2006 597

Copy of report to be delivered to registrar

(1)
A company to which a report is made under section 593 as to the value of any consideration for which, or partly for which, it proposes to allot shares must deliver a copy of the report to the registrar for registration.

(2)
The copy must be delivered at the same time that the company files the return of the allotment of those shares under section 555 (return of allotment by limited company).


(3)
If default is made in complying with subsection (1) or (2), an offence is committed by every officer of the company who is in default.


(4)
A person guilty of an offence under this section is liable—


(a)
on conviction on indictment, to a fine;


(b)
on summary conviction, to a fine not exceeding the statutory maximum and, for continued contravention, a daily default fine not exceeding one-tenth of the statutory maximum.

[redhill9] 16/6/2016 15:02

I assume SK gets paid per word posted rather than by quality or originality of content.

[supersonico] 16/6/2016 10:47

SK you seem to be repeatedly asking us to believe that despite all of Frothys noise Shore Cap overlooked and LivingBridge ignored or did not investigate all of the points Frothy was making, which to me is implausible especially considering the potential damaging reputational and financial consequences ..as Redhill9 pointed out earlier.

Your argument and unwillingness to call Shorecaps behaviour wilfull blindness further weakens your case IMO.

It's obvious to anyone reading both you and Frothy are avoiding the swing.

FRC 128..........

[quazie12] 15/6/2016 23:44

SKNothing at close of play today, I'm sure it will appear eventually. In any case I'm quite confident the Terpenetech valuation will be full of disclaimers and I have doubt that the Valuer will not be a KPMG or PWC either.It's more likely to be their current auditors. They may be in attendance at the next AGM so maybe some questions could be asked there/then. What I forgot to mention to the trolls earlier was that I actually bought a coupe of Eden's shares again purely so that I could make any enquiries as a shareholder so I'm still losing !Q12

[quazie12] 15/6/2016 19:14

LR2I find it more odd that you guys have no real problems with the TT deal and Supersonico gets frenzied about TW/SK and what they say/didn't say rather than real issuesOn the subject of company attackers (and I have no problem with those who attack on BB's or with shorters, it keeps the market real) there's only one way you get the better of them and that's where you continue to hold or even add to your investment if you are convinced of the story, then of course the company needs to deliver on its promises.

[lr2] 15/6/2016 17:55

It still strikes me as odd Quazie that you only made one single posting here during the 10 years you say you held Eden but have subsequently made 105 more posts since you say you sold out.

To give you your due however, I don't ever recall you saying anything about Eden being fraudulent.

[redhill9] 15/6/2016 17:31

Q12, fair enough, I wasn't suggesting you had anything to do directly with SK but you do seem to be influenced by him. Maybe you just believe what he says, which is your choice.

Regarding the TT deal, yes shareholders were diluted but Eden needed cash for the reasons I mentioned. Remember the shares were issued at a higher share price than it has been since. As for the other comments on the deal I don't agree they are relevant or important - the valuation and revenue treatment are red herrings but I have no intention of getting into a debate about it. Time will show.

[quazie12] 15/6/2016 16:51

RedhillFor the avoidance of doubt, i have nothing to do with SK whatsoever. Further, i have not to my knowledge, ever described the TT deal as fraud, that is a word used by others. Im sure that will set some sad wee troll off trolling over all my earlier posts then smugly repost on here, go ahead sad POS.I think the company have behaved like many AIM co's in the past, more than highly disrespectful to shareholders, overly generous to themselves, claiming constantly about wins and results in the face if minimal revenues. Nothing new and no cause for bitterness.I was a long term holder of Eden until recently, 10 years actually and yes I lost money. I am not bitter, i just lost faith. Didnt like TT transaction, the fact that someone made £320k from the deal, we got diluted again, the shares were probably dumped in the market, i don't believe in the valuation of TT at £3m + and Didnt like the £600k revenue treatment. Still waiting however for the company to discharge their legal obligations and submit the Independent Valuation to Comanies House at time of writing.Why am I on here ? Probably largely due to the troll like attacks from a number of posters when i dared to post something negative back in Feb. I thought "Fk you" for attacking a genuine poster, "fk you" for posting utter sh*te, spinning bullish nonsense to each other giving the impression that anyone who hadnt filled their boots was missing the investment of the century. Irrespective, i have said this before, i genuinely hope genuine LT holders get a result one day. I moved on and dont regret it.Q12

[supersonico] 15/6/2016 13:24

Hey Q12/SK/Frothy


How did Shorecap manage to hide the TT deal from LivingBridge.

.....................................................................................
mean while at Sharepopets HQ

Hey SK

Yes Frothy

Remember don't mention Shore Cap.
Supersonico has asked a question which totally blows my Fraud narrative.
and I can't answer it without getting into deep pooh with Shore Cap.
You and Q12 keep banging on about TT ..I preferred it when the deluded maggot posted in Greek.



OK Frothy

[quazie12] 15/6/2016 13:18

Gemstar2Another troll with a personal attack MO. Thank you for your valuable contribution of criticism of posters and sweet FA else. Just what has the sophistication of my investment ability got to do with anything at all ?You are making a total fool of yourself mate and i suppose its my fault now that your investment is tanking ?Q12

[gemstar2] 15/6/2016 12:32

Quazie, if you are Big Al then you are a very sophisticated investor

And I would only remind you of the words of the beautiful Charlotte Lucas

'not to be a simpleton, and allow her fancy for Wickham to make her appear foolish in the eyes of a man of ten times his consequence '

Wise words

[the prophet] 15/6/2016 12:16

Shore Capital comment on today's news:

EDEN RESEARCH+ (EDEN, House stock at 9p) Label extensions for 3AEY in Spain and Greece. Eden Research (‘Eden’) has announced that, together with its commercialisation partners in Spain (Sipcam Iberia) and Greece (Redestos Group), it has been granted label extensions for the use of 3AEY for a new disease target in Spain and number of additional minor uses in Greece, beyond the original designation for the prevention and treatment of botrytis in table and wine grapes.

In Spain, 3AEY (locally marketed as "ARAW" by Sipcam) has been additionally approved for use in the control of vine powdery mildew. Powdery mildew is one of the most challenging and widespread fungal diseases of grapevines in the world. Powdery mildew manifests itself as a powdery growth on the tissue of the vine and affects both table grapes and wine grapes causing significant crop losses and impacting the quality of wine. In Greece, the authorities have expanded the approval for the use of 3AEY (marketed as Mevalone in Greece and the Balkan states) in the treatment of botrytis on field and greenhouse aubergines, kiwis, pomegranates and fresh onions. Combined, these crops cover more than 14,000 hectares in Greece.

These approvals are the first milestone in the expansion of regulatory clearance for 3AEY outside of the initial authorisation for the prevention and cure of botrytis on table and wine grapes. Together with Redestos Group, Eden is also pursuing authorisation for 3AEY in several countries outside of the EU Southern Zone, and these registrations will be granted in due course, subject to regulatory process and approval.

Today’s announcement follows on from the recent FY2015A preliminary results which highlighted Eden reaching a number of important milestones during the year. The company now looks well positioned with a strong balance sheet post the recent capital raising to deliver further progress in FY2016F. House Stock.

+Shore Capital Stockbrokers Limited acts as broker and Shore Capital & Corporate Limited acts as NOMAD to Eden Research. In line with its conflicts of interest policy, Shore Capital does not make formal recommendations on house stocks.

Phil Carroll – 0151 600 3711

[quazie12] 15/6/2016 12:03

Redhill 9

So effectively you are saying that you are happy with Terpenetech deal ? Wow you are one easily please PI then.

I don't post anything original, so what, not many do, unless of course you count ramptastic sh!te as original thinking which you probably do.

Q12

[the prophet] 15/6/2016 09:19

excellent news. M.cap here look far too low at the mo, picked a few more up yesterday. When you consider just the cost let alone the time of registering a biopesticide is $20m and Eden have three such approvals,then without considering market approvals, market size, other products in the pipeline, commercial tie ups etc etc, then valuation here is very modest, imo.
With money in the bank, a strategic investor on the bod, more deals and news to come then things look good.

[redhill9] 15/6/2016 08:44

Probably not immediately material, but good news nonetheless and another step forward.

Label extensions for 3AEY in Spain and Greece

Date: 7:00 am, 15 Jun 2016

RNS Number : 2059B
Eden Research plc
15 June 2016

Eden Research Plc ("Eden" or "Company")

Label extensions for 3AEY in Spain and Greece

Eden Research plc (AIM: EDEN), the AIM-listed company that provides breakthrough natural microencapsulation technologies to the global agrochemicals, animal health and consumer products industries, announces that, together with its commercialisation partners in Spain (Sipcam Iberia) and Greece (Redestos Group), it has been granted label extensions for the use of 3AEY for a new disease target in Spain and number of additional minor uses in Greece, beyond the original designation for the prevention and treatment of botrytis in table and wine grapes.

In Spain, 3AEY (locally marketed as "ARAW" by Sipcam) has been additionally approved for use in the control of vine powdery mildew. Powdery mildew is one of the most challenging and widespread fungal diseases of grapevines in the world. Powdery mildew manifests itself as a powdery growth on the tissue of the vine and affects both table grapes and wine grapes causing significant crop losses and impacting the quality of wine. In Greece, the authorities have expanded the approval for the use of 3AEY (marketed as Mevalone in Greece and the Balkan states) in the treatment of botrytis on field and greenhouse aubergines, kiwis, pomegranates and fresh onions. Combined, these crops cover more than 14,000 hectares in Greece.

These approvals are the first milestone in the expansion of regulatory clearance for 3AEY outside of the initial authorisation for the prevention and cure of botrytis on table and wine grapes. Together with Redestos Group, Eden is also pursuing authorisation for 3AEY in several countries outside of the EU Southern Zone, and these registrations will be granted in due course, subject to regulatory process and approval.

[quazie12] 14/6/2016 20:33

SSDo you think Livingbridge really gave a Sh1t about the TT deal if it occurred before they invested ? The only real losers were us shareholders, hence the reason I baled out. Without doubt they will have discounted the licensing revenue and stake in TT, (as the market seems to have done ever since) and were prepared simply to take a punt on the story but get a place on the Board to police their investment at the same time.